Page results
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
This page provides information about achalasia and its diagnosis and treatment.
-
This page provides information on Ulcerative Colitis (UC) and how diet can help you manage any symptoms you are managing, improve wellbeing and support a healthy diet during remission.
-
This page provides information on how diet can help to manage the symptoms of Ulcerative Colitis during a flare up known as active Ulcerative Colitis.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
File results
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab